Connecticut Innovations Invests $6.9 Million in Second Quarter
Investments leverage $41.2 million in outside capital in fiscal Q2 FY2019
Rocky Hill, Conn. – February 5, 2019 – Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for the state’s growing companies, today announced that it invested $6.9 million in 24 companies and scientific projects during the three months ending December 31, 2018.
The investments leveraged an additional $41.3 million in capital to further support the growth of these companies. Of the $6.9 million, CI invested $4.3 million in bioscience, $2 million in information technology and $0.5 million in other technologies.
“We continue to invest in thriving Connecticut startup companies in bioscience, healthcare and IT-related fields,” said David Wurzer, executive vice president and chief investment officer at Connecticut Innovations. “Our second-quarter participation as a lead or syndicate investor resulted in an additional $41.2 million of capital being deployed in seven new companies and 17 existing Connecticut startup technology companies and scientific projects.”
About Connecticut Innovations
Connecticut Innovations (CI) is the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. To maximize company growth potential, CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals. For more information, please visit www.ctinnovations.com.
Vice President of Marketing and Communications